Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Heartbeam, Inc. - Common Stock (NQ:BEAT)

1.520 -0.060 (-3.80%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Heartbeam, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q2 2023 Financial Report, Corporate Update
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property Product Safety
HeartBeam Reports Second Quarter 2023 Financial Results
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces First Peer-Reviewed Publication Based on Its VECG Technology
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Heartbeam Inc. (NASDAQ: BEAT) Near the Top of Equities by Percentage Gain on 3/20
Via Investor Brand Network
Topics Credit Cards
Exposures Interest Rates
HeartBeam Announces Publication of Foundational Study on the Detection of Heart Attacks
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Appoints Deborah Castillo to Lead Regulatory Strategy and Execution
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
HeartBeam Appoints Deborah Castillo as Vice President of Regulatory Affairs
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q2 2023 Results Call, Webcast
Via Investor Brand Network
HeartBeam to Host Second Quarter 2023 Results Conference Call on Thursday August 10, 2023 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Experienced Physician, Researcher to Board of Directors
Via Investor Brand Network
HeartBeam Appoints Dr. Michael R. Jaff to the Board of Directors
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Adds Wealth of Expertise to Its Board with Appointments of Ken Nelson and Mark Strome
Via Investor Brand Network
HeartBeam Appoints Ken Nelson and Mark Strome to the Board of Directors
From HeartBeam, Inc.
Via Business Wire
Strategic Alliance with Samsung and Collaboration with Dept. of Veterans Affairs to Advance Use of Unique 3-D Telehealth Technology for Heart Attack Detection and Quicker Response: BEAT
Via Get News
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Enters SAA with Samsung
Via Investor Brand Network
Exposures Product Safety
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Enters SAA with Samsung
Via Investor Brand Network
Exposures Product Safety
HeartBeam (NASDAQ: BEAT) Enters Strategic Alliance Agreement with Samsung for Cardiac Care Solutions
HeartBeam Collaborates with Samsung to Boost Cardiac Diagnostic Capabilities HeartBeam, Inc. (NASDAQ: BEAT), renowned for their pioneering 3D-vector electrocardiogram (VECG) 
Via Spotlight Growth
Exposures Product Safety
HeartBeam Enters into Strategic Alliance Agreement with Samsung
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Granted Key Patent for Use in Innovative System Designed to Help Evaluate Cardiac Symptoms
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
HeartBeam Announces Automated Cardiac Detection Patent Granted for HeartBeam AIMIGo™ System
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces FDA 510(k) Submission of HeartBeam AIMIGo(TM) Solution
Via Investor Brand Network
Exposures Product Safety
HeartBeam Announces FDA Submission of HeartBeam AIMIGo™ VECG System
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q1 2023 Financial Report, Corporate Updates
Via Investor Brand Network
Exposures Product Safety
HeartBeam Reports First Quarter 2023 Financial Results
From HeartBeam, Inc.
Via Business Wire
$25 Million Capital Raise Completed to Support Commercialization of Unique 3-D Telehealth Technology for Heart Attack Detection and Rapid Response: HeartBeam, Inc. (NASDAQ: BEAT)
Via Get News
Topics Credit Cards
Exposures Interest Rates Product Safety
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Completes $25M Capital Raise to Achieve Upcoming Milestones, Extend Cash Runway
Via Investor Brand Network
HeartBeam Completes $25 Million Capital Raise and Updates 2023 Strategic Focus and Financial Guidance
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Poised to Offer Timely Solution amid a ‘Smoldering Public Health Crisis’
Via Investor Brand Network
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Poised to Enable Expedited Care for Heart Attack Patients
Via Investor Brand Network
HeartBeam Inc. (NASDAQ: BEAT) Focuses on CV Solutions as Study Shows CV Disease Rising Among Young Adults
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.